Merck Provides Update on KeyVibe and KEYFORM Clinical Development Programs Evaluating Investigational Vibostolimab and Favezelimab Fixed-Dose Combinations with Pembrolizumab
| 0P00007138 | CAD 54.94 0.18 0.33% |
About 62% of RBC Sciences' investor base is looking to short. The analysis of overall sentiment of trading RBC sciences biologiques fund suggests that many investors are alarmed at this time. The current market sentiment, together with RBC Sciences' historical and current headlines, can help investors time the market. In addition, many technical investors use RBC sciences biologiques fund news signals to limit their universe of possible portfolio assets.
RBC |
Merck , known as MSD outside of the United States and Canada, today announced the discontinuation of the clinical development programs for
Read at businesswire.com
 |
RBC Sciences Fundamental Analysis
We analyze RBC Sciences' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of RBC Sciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of RBC Sciences based on its fundamental data. In general, a quantitative approach, as applied to this fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Number Of Employees
Number Of Employees Comparative Analysis
RBC Sciences is third largest fund in number of employees among similar funds. Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.
RBC sciences biologiques Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with RBC Sciences fund to make a market-neutral strategy. Peer analysis of RBC Sciences could also be used in its relative valuation, which is a method of valuing RBC Sciences by comparing valuation metrics with similar companies.
Peers
RBC Sciences Related Equities
| 0P00007138 | RBC Sciences | 0.33 |
| ||
| 0P00018PVY | RBC European | 1.19 |
| ||
| 0P00007065 | RBC Mondial | 2.28 |
| ||
| 0P00007061 | RBC Canadian | 3.75 |
| ||
| 0P00012UCU | RBC Global | 9.73 |
| ||
| 0P000077P2 | RBC Dividend | 13.84 |
|
Other Information on Investing in RBC Fund
RBC Sciences financial ratios help investors to determine whether RBC Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in RBC with respect to the benefits of owning RBC Sciences security.
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |